Roche’s under-the-skin cancer injection gets Britain’s nodÂ
HQ Team August 30, 2023: Roche’s atezolizumab drug Tecentriq, to treat cancer, was approved by Britain’s Medicines and Healthcare Products Regulatory Agency. Tecentriq.
Drugs
Health
Pharma
Drugs
Health
Pharma
Merck & Co meets breast cancer therapy goal in last-stage trials
HQ Team July 29, 2023: Merck & Co., Inc., announced it has met one of the primary goals during a late-stage trial of.
Drugs
Health
Pharma
USFDA allows first oral contraceptive without a prescriptionÂ
HQ Team July 14, 2023: The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the.
Drugs
Health
Medical
Estrogen fuels breast cancer development, finds study
Researchers say the hormone estrogen causes a molecular dysfunction by altering a cell’s DNA and causing the breast tissue to develop.
Drugs
Health
Pharma
India caps trade margins on 42 anti-cancer medicines
India has put a cap on the trade margin of 42 selected non-scheduled anti-cancer medicines, including ribociclib, which is used to treat breast.
Drugs
Pharma
Novartis AG stops breast cancer trial as it achieves early success
Novartis AG, the world's fourth-largest pharmaceutical company by revenue, announced its Kisqali drug reduced breast cancer recurrence when diagnosed at an early stage.
Drugs
Health
Medical
Leukaemia drug effective in treating breast cancer metastatic relapse
A mice study showed promising results in treating secondary recurrence of breast cancer in lungs
Drugs
Pharma
Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designationÂ
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.
Drugs
Medical
Pharma
Alembic gets USFDA nod for Fulvestrant to treat breast cancer
Alembic Pharma receives USFDA approval for breast cancer drug--Fulvestrant injection